2013 Joint Meeting of the International Cytokine Society & International Society

描述(申请人提供)：国际细胞因子学会(ICS)和国际干扰素和细胞因子研究学会(ISICR)第11届年度联席会议将于2013年9月29日至10月3日在加利福尼亚州旧金山凯悦酒店举行。这次国际会议将汇集细胞因子信号和生物学、免疫学、癌症研究和传染病领域的领先研究人员。本次会议的科学组织委员会由Sarah Gaffen博士(ICS成员主席)、Warren Leonard博士(ICS前主席)、Robert Schreiber博士(前ISICR委员)和Karen Mossman博士担任共同主席；这些科学家共同涵盖了与ICS和ISICR利益相关的广泛的科学专业知识，并作为一个小组拥有良好的工作关系。会议的一个主要目标将是促进科学家与那些致力于将这些知识转化为人类疾病新疗法的科学家之间的互动，这些科学家对细胞因子功能、信号转导和基因表达的分子机制进行尖端研究。细胞因子和细胞因子信号和表达调节剂的治疗潜力得到了很好的评价，这增加了在这一令人兴奋的领域中基础、翻译和临床研究人员之间加强相互作用的需要。除了计划在全体会议和专题讨论会上邀请约65名发言者外，还将挑选一些由登记者提交的摘要在专题会议上作口头陈述，其他登记者将有机会在海报会议上讨论他们的工作。学术机构以及生物技术和制药行业的科学家已被邀请和鼓励参加。这次会议的另一个主要目标是促进年轻研究人员和受训人员与细胞因子领域的知名研究人员的互动，并为这些年轻研究人员介绍他们的工作提供一个论坛。优秀的初级研究人员、博士后研究人员和研究生/医学生也将被鼓励参加，并将向这些类别的年轻研究人员颁发奖项，如本提案正文所述。将特别努力支持任职人数不足的少数群体和妇女的职业发展，2013年会议的一项重要创新是增加了两个讲习班和专门为受训人员和年轻(一年级)教员举行的特别招待会，旨在促进这些互动。组委会坚信，通过将领导人聚集在一起， 对于这些不同细胞因子研究领域的初级研究人员和受训人员，这次会议将启发重要的新调查途径，并将对细胞因子领域有前途的年轻研究人员和受训人员的职业发展大有裨益。

DESCRIPTION (provided by applicant): The 11th Annual Joint Meeting of the International Cytokine Society (ICS) and the International Society for Interferon and Cytokine Research (ISICR) will be held in San Francisco, California at the Hyatt Regency Embarcadero from September 29 - October 3, 2013. This international conference will bring together leading investigators in the fields of cytokine signaling and biology, immunology, cancer research, and infectious diseases. The Scientific Organizing Committee for this meeting is co-chaired by Dr. Sarah Gaffen (ICS Membership Chair), Dr. Warren Leonard (former president of ICS), Dr. Robert Schreiber (former Councilor of ISICR), and Dr. Karen Mossman; together, these scientists cover a broad spectrum of scientific expertise relevant to the interests of the ICS and ISICR, and have an excellent working relationship as a group. A major goal of the meeting will be to promote interactions between scientists performing cutting-edge studies of the molecular mechanisms of cytokine function, signal transduction, and gene expression, and those working to translate this knowledge into novel therapies for human disease. The therapeutic potential of cytokines and of modulators of cytokine signaling and expression are well appreciated, raising the need for enhanced interactions between basic, translational, and clinical researchers in this exciting field. In addition to approximately 65 invited speakers scheduled for Plenary Sessions and Symposia, a number of abstracts submitted by registrants will be selected for oral presentations in Special Topics Sessions, with other registrants given the opportunity to discuss their work at poster sessions. Scientists from academic institutions as well as from the biotechnology and pharmaceutical industries have been invited and encouraged to participate. Another major goal of this meeting is to facilitate interactions of young investigators and trainee with well-established researchers in the cytokine fields and to provide a forum for these young investigators to present their work. Outstanding junior investigators, postdoctoral researchers, and graduate/medical students will also be encouraged to participate, and awards will be given to young researchers in each of these categories, as described in the body of this proposal. A special effort will be made to support the career development of under-represented minorities and women, and an important innovation of the 2013 meeting is to add 2 workshops and a special reception exclusively for trainees and young (1st year) faculty, designed to foster these interactions. It is the firm belief of the Organizing Committee that, by bringing together leaders, junior investigators, and trainees in these diverse areas of cytokine research, this meeting will inspire important new avenues of investigation and will be of great benefit to the career development of promising young investigators and trainees in the cytokine field.